[go: up one dir, main page]

MX2022007009A - Composicion topica y metodos de medicion de la capacidad de refrigeracion de una composicion. - Google Patents

Composicion topica y metodos de medicion de la capacidad de refrigeracion de una composicion.

Info

Publication number
MX2022007009A
MX2022007009A MX2022007009A MX2022007009A MX2022007009A MX 2022007009 A MX2022007009 A MX 2022007009A MX 2022007009 A MX2022007009 A MX 2022007009A MX 2022007009 A MX2022007009 A MX 2022007009A MX 2022007009 A MX2022007009 A MX 2022007009A
Authority
MX
Mexico
Prior art keywords
composition
measuring
methods
refrigeration capacity
volatile solvents
Prior art date
Application number
MX2022007009A
Other languages
English (en)
Inventor
Adrian Davis
Original Assignee
Futura Medical Developments Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=73040144&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2022007009(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB1918039.7A external-priority patent/GB201918039D0/en
Priority claimed from GBGB2015404.3A external-priority patent/GB202015404D0/en
Application filed by Futura Medical Developments Ltd filed Critical Futura Medical Developments Ltd
Publication of MX2022007009A publication Critical patent/MX2022007009A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N25/00—Investigating or analyzing materials by the use of thermal means
    • G01N25/20—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity
    • G01N25/48—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation
    • G01N25/4846—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation for a motionless, e.g. solid sample
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N25/00—Investigating or analyzing materials by the use of thermal means
    • G01N25/56—Investigating or analyzing materials by the use of thermal means by investigating moisture content
    • G01N25/58—Investigating or analyzing materials by the use of thermal means by investigating moisture content by measuring changes of properties of the material due to heat, cold or expansion

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Combustion & Propulsion (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Se proporciona una composición para aplicación tópica en el pene para el tratamiento de la disfunción eréctil, la composición está libre de trinitrato de glicerilo (GTN), sildenafilo y un inhibidor de la acetilcolinesterasa, y comprende disolventes volátiles y no volátiles, comprendiendo los disolventes volátiles un alcohol inferior y agua. y los disolventes no volátiles que comprenden un alcohol polihídrico y un glicol; preferiblemente, la composición no contiene ningún ingrediente farmacéuticamente activo para el tratamiento de la disfunción eréctil; también se proporciona un método para determinar la capacidad de enfriamiento de una composición de prueba, tal como la composición descrita anteriormente.
MX2022007009A 2019-12-09 2020-10-22 Composicion topica y metodos de medicion de la capacidad de refrigeracion de una composicion. MX2022007009A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1918039.7A GB201918039D0 (en) 2019-12-09 2019-12-09 Topical composition
GBGB2015404.3A GB202015404D0 (en) 2020-09-29 2020-09-29 Topical composition
PCT/GB2020/052660 WO2021116651A1 (en) 2019-12-09 2020-10-22 Topical composition and methods of measuring the cooling abaility of a topical composition

Publications (1)

Publication Number Publication Date
MX2022007009A true MX2022007009A (es) 2022-08-25

Family

ID=73040144

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022007009A MX2022007009A (es) 2019-12-09 2020-10-22 Composicion topica y metodos de medicion de la capacidad de refrigeracion de una composicion.

Country Status (15)

Country Link
US (2) US12414992B2 (es)
EP (2) EP4342494A3 (es)
KR (1) KR20220124712A (es)
CN (1) CN115003278B (es)
AU (1) AU2020401440A1 (es)
BR (1) BR112022011284A2 (es)
CA (1) CA3160206A1 (es)
DK (1) DK3934624T3 (es)
ES (1) ES2978421T3 (es)
FI (1) FI3934624T3 (es)
MX (1) MX2022007009A (es)
PL (1) PL3934624T3 (es)
PT (1) PT3934624T (es)
TW (1) TWI896577B (es)
WO (1) WO2021116651A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119112770B (zh) * 2023-12-27 2025-09-05 江苏澳德智科医疗科技有限公司 一种功能凝胶的制备方法
US12517073B2 (en) * 2024-01-25 2026-01-06 Futura Medical Developments Limited Topical composition testing method and apparatus
GB202402524D0 (en) * 2024-02-22 2024-04-10 Futura Medical Developments Ltd Topical composition
CN118576540A (zh) * 2024-07-30 2024-09-03 杭州启真求实科技有限公司 一种用于男性勃起障碍外用的组合物凝胶及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2716739B2 (ja) * 1988-07-26 1998-02-18 インデナ エス．ピー．エイ 血管運動作用を有する化粧用組成物
US5093133A (en) * 1990-01-24 1992-03-03 Mcneil-Ppc, Inc. Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
US5942545A (en) 1998-06-15 1999-08-24 Macrochem Corporation Composition and method for treating penile erectile dysfunction
US6435710B1 (en) 1998-08-26 2002-08-20 Fauske & Associates, Inc. Foam detector apparatus and method
US6333039B1 (en) * 1998-09-25 2001-12-25 Gojo Industries, Inc. Opaque skin sanitizing composition
US6183766B1 (en) * 1999-02-12 2001-02-06 The Procter & Gamble Company Skin sanitizing compositions
GB0602224D0 (en) * 2006-02-03 2006-03-15 Futura Medical Dev Ltd Composition for promoting vascular smooth muscle relaxation
RU2342923C1 (ru) * 2007-07-26 2009-01-10 Общество с ограниченной ответственностью "Бентус лаборатории" Дезинфицирующее антисептическое средство для обработки рук с увлажняющим эффектом (варианты)
US20090318510A1 (en) * 2008-06-24 2009-12-24 Glycobiosciences, Inc. Topical drug delivery system
EP2147674A1 (en) * 2008-07-24 2010-01-27 Besins Healthcare Transdermal pharmaceutical compositions comprising danazol
WO2010044094A2 (en) 2008-09-03 2010-04-22 Krishna Radharaman Agarwal A topical composition for the treatment of erectile dysfunction
US20140227342A1 (en) 2013-02-08 2014-08-14 Michael Farber Acetylcholinesterase inhibitor composition for sexual use
JP6622217B2 (ja) * 2014-04-21 2019-12-18 アクラリス セラピューティクス、インク． 過酸化物製剤ならびにその使用のための方法および塗布器
GB201609968D0 (en) * 2016-06-07 2016-07-20 Futura Medical Dev Ltd Topical pharmaceutical formulation
GB201713160D0 (en) 2017-08-16 2017-09-27 Futura Medical Dev Ltd Topical composition
AU2019276832B2 (en) * 2018-06-01 2024-08-15 Tavanta Therapeutics, Inc. Topical amlodipine salts for the treatment of anorectal diseases

Also Published As

Publication number Publication date
DK3934624T3 (da) 2024-06-10
FI3934624T3 (fi) 2024-05-24
PT3934624T (pt) 2024-04-23
CN115003278B (zh) 2025-12-30
US20230022570A1 (en) 2023-01-26
PL3934624T3 (pl) 2024-07-08
WO2021116651A1 (en) 2021-06-17
US12414992B2 (en) 2025-09-16
CN115003278A (zh) 2022-09-02
ES2978421T3 (es) 2024-09-12
EP4342494A2 (en) 2024-03-27
CA3160206A1 (en) 2021-06-17
EP3934624A1 (en) 2022-01-12
AU2020401440A1 (en) 2022-06-16
US20250352650A1 (en) 2025-11-20
KR20220124712A (ko) 2022-09-14
EP3934624B1 (en) 2024-03-13
TWI896577B (zh) 2025-09-11
BR112022011284A2 (pt) 2022-09-06
EP4342494A3 (en) 2024-06-05
TW202135785A (zh) 2021-10-01

Similar Documents

Publication Publication Date Title
MX2022007009A (es) Composicion topica y metodos de medicion de la capacidad de refrigeracion de una composicion.
CL2017003445A1 (es) Formas solidas y formulaciones de compuestos de imidazopirazina.
EA201500432A1 (ru) Соединения боронатного эфира и его фармацевтические составы
CL2020002252A1 (es) Formulación oftálmica.
EA202192322A1 (ru) Фармацевтические составы
EA200970928A1 (ru) Антагонисты рецептора гонадотропин-рилизин-фактора и способы их применения
EA200700892A1 (ru) Липосомная композиция, содержащая активное вещество для релаксации гладкой мускулатуры, получение этой композиции и ее терапевтическое применение
EA200970348A1 (ru) Новые инъецируемые депо-композиции и способ получения таких композиций
EA201591751A1 (ru) Трипептидные эпоксикетонные ингибиторы протеазы
EA201390803A1 (ru) Ингибиторы бромодомена и их применение
EA200800161A1 (ru) Новые фармацевтические композиции с модифицированным высвобождением и способ получения таких композиций
MX2022001743A (es) Formas en estado solido de (s)-2-(((s)-6,8-difluor-1,2,3,4-tetrahi dronaftalen-2-il)amino)-n-(1-(2-metil-1-(neopentilamino)propan-2- il)-1h-imidazol-4-il)pentanamida y usos de la misma.
EA201791289A1 (ru) Ингибиторы клеточного некроза и связанные с ними способы
MX2024013019A (es) Compuestos de heteroarilo para el tratamiento del dolor
JOP20200100A1 (ar) مشتقات بيرازولو-بيرولو-بيريميدين-ديون جديدة كمثبِّطات لـ p2x3
AR123861A1 (es) Politerapia de antagonistas de unión al eje pd-1 e inhibidores de lrrk2
EA202192845A1 (ru) Новые композиции, содержащие мелфлуфен
DK1414467T3 (da) Topisk behandling af mastalgi
DK1638582T3 (da) Anvendelse af hyaluronsyre til fremstilling af kompositioner til behandling af tilbagevendende after
MX2023007091A (es) Composiciones oftalmicas que contienen una prostamida liberadora de oxido nitrico.
EA202192422A1 (ru) Человеческий сывороточный альбумин в составах
MX2022004806A (es) Metodos y composiciones para tratar la anemia drepanocitica con un inhibidor de la ferroportina (vit-2763).
RU2012135798A (ru) Фармацевтическая композиция для лечения зуда кожи
EA201992149A1 (ru) Комбинация активных ингредиентов, содержащие ее композиции и их применение в лечении саркопении
EA201892532A1 (ru) Пиримидин-2-иламино-1н-пиразолы в качестве ингибиторов lrrk2 для применения при лечении нейродегенеративных заболеваний